Background. Long-term peritoneal dialysis (PD) is associated with peritoneal fibrosis and loss of function. It has been shown that activation of the adenosine A 2A receptor (A 2A R) promotes tissue repair, wound healing and extracellular matrix (ECM) production. We have previously shown that adenosine is a potent regulator of inflammation in the peritoneum. In the current study, we explored the role of adenosine and the A 2A R in two experimental models. Methods. Collagen deposition was evaluated in primary peritoneal fibroblasts following treatment with an A 2A R agonist and antagonist. In addition, peritoneal fibrosis was induced by i.p. injection of either chlorhexidine gluconate for 2 weeks or 4.25% glucose peritoneal dialysis fluid (PDF) for 1 month. The development of fibrosis was compared between wild-type (WT) and WT mice treated with caffeine (an A 2A R antagonist) in drinking water or between (A 2A R +/+ ) mice and A 2A R-deficient mice (A 2A R −/− ). Results. Adenosine or the A 2A R agonist CGS21680 stimulated collagen production by peritoneal fibroblasts in vitro and A 2A R antagonists (ZM241385 and caffeine) blocked this effect. Consistent with these results, caffeine-treated WT or A 2A R −/− mice had reduced submesothelial thickness, collagen deposition and mRNA levels of fibroblastspecific protein (FSP-1) and connective tissue growth factor (CTGF). In addition, treatment with caffeine in vitro and in vivo diminished A 2A R and A 2B R mRNA levels induced by CG or PDF while it upregulated A 1 R levels. Conclusion. Our data suggest that adenosine through its A 2A R promotes peritoneal fibrosis and therefore should be considered as a target for pharmacological intervention.
Introduction
Progressive deterioration of the peritoneal membrane function has been documented in almost half of peritoneal dialysis (PD) patients [1, 2] . Pathologic studies of the peritoneum of patients on long-term PD revealed loss or degeneration of the mesothelial layer, an increased density of blood vessels and submesothelial thickening due to accumulation of collagen [1, 3] . Honda et al. found a correlation between these morphologic changes and loss of ultrafiltration capacity [4] . It has been shown that thickening, due to fibrosis, increases significantly with the duration of PD treatment from 180 µm (0 to 24 months) reaching a value of 700 µm in patients more than 97 months [1] . The mechanisms underlying the fibrotic changes and vasculopathy on long-term PD remain unclear. Damage to the peritoneum may be due to use of PD solutions that have non-physiological features such as low pH, high lactate, hyperosmolarity, high glucose and glucose degradation products (GDP) [5] [6] [7] and also due to repeated episodes of bacterial peritonitis. During peritonitis, several cytokines such as IL-1β and transforming growth factor-β (TGF-β) are upregulated and have been identified in vivo and in vitro as having strong fibrogenic properties through upregulation of and extracellular matrix (ECM) production [8] .
Adenosine is an endogenous purine nucleoside that promotes the resolution of peritonitis by decreasing leukocyte infiltration and cytokine production in the peritoneum through ligation to its A 2A receptor (A 2A R) [9] [10] [11] . In addition, it has been shown that the A 2A R also promotes tissue repair, wound healing and ECM production [12] . In animal models of hepatic fibrosis or dermal fibrosis, A 2A Rdeficient mice or treatment with the A 2A R antagonist diminished the development of fibrosis [13, 14] . The effects of adenosine are mediated through at least four different receptors: A 1 , A 2A , A 2B and A 3 , the A 1 receptor (A 1 R) and A 3 receptor (A 3 R), by interacting with members of the Gi/Go family, decreasing cAMP levels [15, 16] . In contrast, the A 2A R interacts with the G-protein Gs and the A 2B receptor (A 2B R) interacts with the G-proteins Gs and Gq that increase cAMP levels [17] . These increased cAMP levels lead to immunosuppressive effects [18] .
Since adenosine through its A 2A R is involved in inflammation processes in the peritoneum and also promotes tissue repair, we hypothesized that adenosine may be involved in the development of peritoneal fibrosis. Indeed, our results show that adenosine through its A 2A R stimulates collagen production in peritoneal fibroblasts. A 2A R-deficient mice developed moderate peritoneal fibrosis induced by Blocking adenosine A 2A R reduces peritoneal fibrosis in two independent experimental models 2393 administration of CG [19] or hypertonic peritoneal dialysis fluid (PDF) (Dianeal 4.25%) in comparison to their wild-type (WT) littermates. These results implicate a major involvement of adenosine in peritoneal fibrosis.
Subjects and methods

Animals
Mice (ICR, Harlan, Jerusalem, Israel) were provided with water with or without caffeine and unlimited standard laboratory rodent food throughout the study. The local Institutional Animal Experiments Committee approved all experimental procedures. A 2A R −/− mice were graciously donated by Catherine Ledent (Université Libre de Bruxelles, Bruxelles, Belgium) [20] .
Adenosine agonists and antagonists
The following adenosine agonists and antagonists were used: adenosine (Adenocor, Sanofi Winthrop, Auckland, New Zealand); A 2A R antagonist 4-(2-[7-amino-2-(2-furyl) [ 
Induction of peritoneal fibrosis
Adenosine A 2A R −/− and its respective WT littermate controls were treated with 0.3 ml of 0.1% CG (Teva Medical, Natanya, Israel) and 15% ethanol [in saline intraperitoneally (i.p.) every 2 days] or with 2 ml of hypertonic PDF (Dianeal 4.25%, Baxter, Deerfield, IL, USA, intraperitoneally every 2 days). Caffeine (0.1% w/v) was administrated in drinking water [16] during the entire period of treatment.
Histological assessment and quantification of the submesothelial compact zone
Biopsies of the parietal peritoneal membrane were taken from the same area and at the same size (5 mm 2 ) by puncture with a square cutter. Then sections were fixed in 10% formalin and embedded in paraffin. From each biopsy we did at least three double sections from different part of the biopsy which were stained with hematoxylin and eosin (HE) or Masson's trichrom. These preparations were scored blindly and randomly by an expert histopathologist. Using the Image J software (National Institute of Health), we have calculated the mean width by dividing the submesothelial compact zone area with the corresponding length of each preparation. Similarly, the mean optical density of collagen fibrils was obtained by dividing the optical density of the fibrotic area by the corresponding pixel number. The image analysis was done blindly on three histology sections from each animal.
Quantification of collagen production by the Sircol assay
The collagen levels in lysates of the peritoneal membrane and in supernatants of cultured mesothelial cells or fibroblasts (40 µl/each) were analysed in triplicate by the Sircol collagen dye-binding assay according to the manufacture's protocol (Biocolor, Newtownabbey, UK). To obtain peritoneal lysates for this assay, biopsies of the parietal peritoneal membrane from the same area and at the same size were taken with a square cutter. The samples were homogenized and shaken for 18 h in 0.5 M acetic acid with pepsin (Sigma) and supernatants were collected after centrifugation at 15 000 g for 60 min.
Collection of peritoneal lavage fluids and cytokine detection
At different time points, peritoneal lavage was performed as described [10] . TGF-β levels were determined by the commercial ELISA kit (R&D Systems, Minneapolis, MN, USA).
Preparation of cultured peritoneal fibroblasts
Mouse peritoneal fibroblast cells were obtained from the peritoneal membrane of CD1 mouse. The membrane was washed with PBS and then sliced into portions (∼1-2 mm 2 ). Disaggregation was performed by continuous stirring of the tissue for 1 h at 37 • C in the presence of 0.2% collagenase B (Boehringer Mannheim, Mannheim, FRG) in DMEM. The disaggregated tissue was separated from tissue debris by Histopaque-1077 (Sigma). The cells were suspended in DMEM supplemented with 10% fetal calf serum (FCS), 2 mmol/l L-glutamine, 100 U/ml penicillin and 100 µg/ml streptomycin (Biological Industries, Bet Haemek, Israel). Experiments were performed on cells from the second to fourth passages in 5% FCS. Each fibroblast batch was characterized for its uniform fibroblastoid morphology and was positive for vimentin (Sigma) by indirect immunofluorescence. The cultured cells were tested to be negative for cytokeratin 18 staining (Sigma) that is specific for mesothelial cells, for CD68, a macrophage/monocyte marker (Dako, Copenhagen, Denmark) and for Factor VIII, a marker of endothelial cells. Also, mRNA levels of fibroblast-specific protein (FSP-1), a specific marker for fibroblasts [21] , were examined by RT-PCR.
Preparation of cultured peritoneal mesothelial cells
To prepare peritoneal mesothelial cells (PMC), the peritoneum was removed from 8 newborn (2-week old) mice and isolated, as previously described [22] . The samples of each PMC preparation were morphologically inspected, as previously described [23] . Cells were grown in M199 and supplemented with 10% FCS, 2 mmol/l L-glutamine, 100 U/ml penicillin and 100 µg/ml streptomycin (Biological Industries).
mRNA analysis
Total RNA was extracted from peritoneal fibroblasts or from the peritoneal membrane using the Versagene RNA cell kit (Gentra Systems, Minneapolis, MN, USA). cDNA was prepared as previously described [24] . Quantitative real-time PCR (QPCR) assays were carried out for β-actin, GAPDH, A 1 cDNAs were diluted 9-fold, mixed with primers (0.2 mM) and Thermo start master mix (ABgene, Surrey, UK). Reaction was carried out in a Rotor-Gene real-time PCR machine (Corbett-Research, Northlake, Australia).
Statistical analysis
Data are presented as mean ± SEM. Statistical analysis was performed by the t-test or ANOVA followed by the Tukey post-test. P-values <0.05 were considered significant.
Results
A 2A R agonist induces collagen production in peritoneal fibroblasts
To examine the effect of adenosine on the production of collagen, we treated PMC with the A 2A R agonist, CGS21680. As shown in Figure 1A , CGS21680 (0.1-10 µM) had no effect on collagen production by PMC. Since fibroblasts are the dominant cells in fibrotic processes responsible for ECM deposition, we examined their response to the A 2A R agonist. For that purpose, we isolated primary peritoneal fibroblasts and characterized them for vimentin positive ( Figure 1B ) and negative for endothelial and mesothelial cell markers (not shown). We treated the fibroblasts with adenosine or with the A 2A R agonist, CGS21680 (0.1-10 µM) in the presence or absence of the A 2A R antagonist ZM241385 (10 nM) for 24 h and then determined collagen levels in the media. We found that both adenosine and CGS21680 upregulated collagen production in a dose-dependent manner (∼4-fold of CT at 0.1 µM), while ZM241385 blocked induction of collagen induced by CGS21680. At the highest CGS21680 concentration, 10 µM, we found a decrease in collagen levels that may be due to non-specific activation by the A 2A R agonist ( Figure 1C) . Similar to the effect of ZM241385, treatment with caffeine, which mainly antagonizes the A 2A R in physiological relevant concentrations [25] , diminished the upregulation of collagen by CGS21680 to baseline levels ( Figure 1D ). Treatment with A 1 R, A 3 R antagonists in the presence of adenosine or CGS21680 did not have any effect on collagen production (data not shown).
Oral treatment of caffeine reduced peritoneal fibrosis induced by CG or PDF
Since we found that caffeine blocked collagen production induced by the A 2A R agonist, we next examined the effect of oral treatment with caffeine in mice induced fibrosis. We induced peritoneal fibrosis in mice by administration of CG or hypertonic PDF. As shown in Figure 2A , thickening of the submesothelial space associated with fibrosis appear after only 2 weeks of treatment with CG and at 4 weeks following PDF treatment. These time points were set in preliminary kinetics experiments (not shown) in order to find the earliest time point of significant thickening of the submesothelial space. Treatment with caffeine (0.1% w/v) in mice administrated with CG or PDF caused a significant reduction of the submesothelial width (34% or 40% reduction, respectively), collagen deposition (27% or 45% reduction, respectively) and mRNA levels of FSP-1 (65% and 62% reduction, respectively) in comparison to mice administrated with CG or PDF without caffeine (Figure 2A-C) . Blind and randomized evaluation by a histopathologist also revealed significantly reduced fibrotic development in caffeine treated mice compared to WT mice (data not shown). Both TGF-β and CTGF are known to synergize to promote chronic fibrosis through upregulation of ECM production [8] . Basal TGF-β levels in lavage fluid were not different between WT mice (26 ± 13 pg/ml) and caffeine treated mice (22 ± 7 pg/ml). In contrast, mice administrated with CG or PDF had higher levels in the peritoneum cavity of both TGF-β and CTGF (∼2.5-fold and ∼13-fold of mice treated with vehicle, respectively), while in mice administrated with CG or PDF and treated with caffeine, we found lower levels of TGF-β and CTGF mRNA levels in comparison to mice treated only with CG or PDF (54 and 66% reduction for TGF-β, 54 and 87% for CTGF, respectively, Figure 2D ).
Expression of adenosine receptors in peritoneal fibroblasts in response to adenosine
Since we found that adenosine mediates collagen production through the A 2A R, we determined the expression of adenosine receptors in the presence of adenosine. We treated peritoneal fibroblasts with adenosine (0.1, 1, 10 µM) in the presence or absence of caffeine (100 µM) for 3 h. As shown in Figure 3A and B, A 2A R and A 2B R mRNA levels were upregulated by adenosine (in 0.1 and 1 µM), while in the presence of caffeine this effect was diminished. On the other hand, A 1 R mRNA levels were downregulated in response to adenosine (in 1 and 10 µM) and returned to basal levels in the presence of caffeine ( Figure 3C) . A 3 R mRNA levels were under detection levels (data not shown).
In vivo expression of adenosine receptors
Given that we demonstrated, in vitro, that adenosine receptors respond differently to adenosine and caffeine, we wanted to elucidate the regulation of those receptors during peritoneal fibrosis and in response to treatment with caffeine. We found a similar pattern in both models: administration of CG or PDF caused an upregulation of A 2A R and A 2B R mRNA levels, while there was no significant change in A 1 R mRNA levels (Figure 4) . However, in animals treated with caffeine, the mRNA levels of A 2A R and A 2B R returned to basal levels while A 1 R mRNA levels were upregulated (∼4.5-fold of vehicle).
Reduced development rate of peritoneal fibrosis induced by CG or PDF in A 2A R −/−
To ensure that the effect of caffeine on the development of fibrosis is due to blocking of the A 2A R, we induced fibrosis in A 2A R −/− mice and their WT littermates. As shown in Figure 5A -C, A 2A R −/− mice compared to WT mice administrated with CG or PDF exhibited significantly less collagen deposition as demonstrated by a decrease in the relative width of the submesothelial zone (35 and 27% reduction, respectively), and decrease in collagen deposition as reflected by reduction of the mean density of the blue stain in the CG model (32% reduction), in Masson's trichrom stains of histological preparation. Blind and randomized evaluation by a histopathologist also revealed significantly reduced fibrotic development in A 2A R −/− mice compared to WT mice (data not shown). Moreover, direct evaluation of collagen by the Sircol assay in A 2A R −/− mice showed a decrease of ∼30% in collagen deposition in both models ( Figure 5C ). FSP-1, which is a highly specific marker of fibroblasts and has been shown to be upregulated during fibrotic processes, was indeed upregulated in CG-and PDFinduced fibrosis, but this upregulation was less pronounced in A 2A R −/− mice compared to WT mice (26 and 64% reduction in the mRNA level, respectively). In addition, we found an ∼7-fold increase of CTGF mRNA levels in CGand PDF-induced fibrosis, while in fibrotic A 2A R −/− mice we found a reduction in CTGF mRNA levels of 50% in the CG model and 68% in the PDF model compared to the levels in the corresponding fibrotic models in WT mice.
Discussion
Our results demonstrate that adenosine by acting through the A 2A R plays an important role in the pathogenesis of peritoneal fibrosis.
We have shown in previous studies that adenosine through the A 2A R decreases cytokine secretion and leukocyte recruitment during peritonitis [9] . In the current study, we demonstrate that the A 2A R agonist promotes collagen production from primary peritoneal fibroblasts. Interestingly, we found that it had no effect on collagen production by mesothelial cells. This would suggest that the profibrotic effect of adenosine is mainly targeted at the fibroblasts that are the principal cell population responsible for ECM deposition during tissue repair and pathological fibrotic processes.
Tissue repair and fibrosis follow inflammation, and accumulated data indicate that endogenously released adenosine, acting through A 2A R, suppresses inflammation and promotes repair [12] . This has been demonstrated in several models. For example, topical application of the A 2A R agonist significantly accelerated excisional wound closure in mice [12] . Adenosine also stimulated wound healing in bronchial epithelial cells [26] , and chronic elevation of adenosine levels are associated with the development of pulmonary fibrosis in lungs of adenosine deaminase KO mice [27, 28] .
In order to determine the involvement of adenosine in peritoneal fibrosis, we mimicked the pathological changes that occur in the peritoneal membrane of long-term PD patients using two different models that induce fibrosis by different mechanisms. CG is a chemical that induces fibrosis mainly through direct irritation of the cell membrane, and glucose and glucose degradation products are the main mediators of fibrosis induced by hypertonic PDF [29, 30] .
Regardless of the fibrotic model we used, oral treatment with caffeine caused a reduction in the submesothelial zone, collagen deposition, CTGF mRNA levels and TGF-β. We can assume, therefore, that the effect of caffeine is generally 'antifibrotic' rather than specific to the inducer of fibrosis.
These data are consistent with the study conducted by Gressner et al. who showed that caffeine inhibits TGF-β and CTGF expressions in hepatocytes [31] .
Treatment with caffeine also had an effect on adenosine receptor expression; caffeine diminished A 2A R and A 2B R mRNA levels in vitro and in vivo while upregulating A 1 R levels. The increase of A 1 R expression and the blocking of the A 2A R may make the former more available for activation by adenosine. Contrary to the A 2A R, A 1 R is a G i -coupled receptor that mediates the decrease in cAMP levels. Therefore, its activation may lead to reduction in the development of fibrosis. This should be further examined by using a specific agonist and/or antagonists for these receptors. Recent epidemiological studies support the positive effect of caffeine on fibrosis; these studies showed a milder course of liver fibrosis in patients with higher caffeine consumption [32] .
However, before we recommend the use of caffeine, we should take into account that although it may prevent fibrosis, it may also lead to ongoing inflammation in cases of peritonitis as described previously [9] . It is essential, therefore, to test the long-term effects of caffeine in animal models and also to conduct an epidemiological retrospective study on PD patients.
In order to confirm our hypothesis that the effect of caffeine is mediated through the blocking of the A 2A R, we induced fibrosis in A 2A R knockout mice (A 2A R −/− ). Correspondingly to our results obtained with caffeine treatment, A 2A R −/− mice exhibited a 30-40% decreased submesothelial zone and less collagen deposition compared to their WT littermates.
Long-term treatment of uraemic patients with PDF is associated with vasculopathy and vascularization. Adenosine through activation of the A 2A R was shown to promote angiogenesis in several experimental models. For example, in vitro, the A 2A R promotes endothelial cell proliferation, migration and production of vascular endothelial growth factor (VEGF) [33] [34] [35] . In A 2A R KO mice, Montesinos et al. have shown less microvessel formation in a model of air pouch [12] . Based on these studies, it is reasonable to suggest that treatment with the A 2A R antagonist will also be beneficial in preventing neovascularization in the peritoneum. This hypothesis needs to be further investigated in order to be completely validated.
In conclusion, the blockade of the A 2A R either genetically or by a specific agonist significantly reduced the development of peritoneal fibrosis in the two independent models. In light of these results, a new treatment based on a specific adenosine receptor antagonist should be considered for preventing or at least delaying peritoneal fibrosis in PD-treated patients.
